- 中文名称
Influenza A, IgM, BioAssay ELISA Kit Not for use in USA, for Export use only
- 英文名字
- Influenza A, IgM, BioAssay ELISA Kit Not for use in USA, for Export use only
- 供应商
- USBiological
- 产品货号
- I7649-53
- 产品报价
- ¥1/1Kit

- 产品说明书
- 点击查看
- 购买方式
- 银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868
- 产品新闻

- 背景资料
- USBiological品牌是全球有名的抗原抗体和生化试剂供应商,生产世界上种类最多的抗体,用于Western Blot、免疫沉淀、免疫荧光、免疫组化和流式细胞术等多种检测方法。武汉艾美捷科技作为USBiological品牌中国区域总代理,是行业中少有的致力于服务客户,帮助客户,且拥有独立的专业销售团队、技术支持团队、市场营销团队、进出口报关团队的高科技生物企业。可以为您提供及时的咨询响应,专业的产品和解决方案支持,稳健快捷的交货周期,优质放心的售后服务。我们致力于为您提供有价值的产品和服务,在意您的成功!
- 产品描述
- Enzyme immunoassay for the detection and quantitative determination of human IgM antibodies against Influenza A in serum and plasmaIntended Use:The Influenza A IgM Antibody ELISA Test Kit has been designed for the the detection and the quantitative determination of specific IgA antibodies against Influenza A in serum and plasma. Further applications in other body fluids are possible and can be requested from the Technical Service of United States Biological. This assay is intended for in-vitro diagnostic use only. Laboratory results can never be the only base of a medical report. The patient history and further tests have additionally to be taken into account.The influenza infection is an acute feverish virus infection, which principally leads to an illness of the respiratory tract and appears as an epidemic or pandemic. The infection mostly results from a droplet infection. The virus spreads from the mucous membrane of the upper respiratory to the whole bronchial tract. There the virus and its toxin can lead to a serious inflammation of the bronchial mucosa and a damage of the vessels. After an incubation time of 1 to 3 days the symptoms appear suddenly; followed by a fast increase of temperature, often accompanied by shivering, the catarrhal leading symptom appears, which contribute to the clinical course beside painful dry cough, tracheitis, laryngitis and frequently a rhinitis and conjunctivitis. The Influenza viruses form a virus group with principally similar morphological, chemical and biological features. The types A, B and C were defined, from which many other variants are known.The distinction of the types will be possible by the different antigenicity of their nucleoproteins, which are coated by a matrix protein with type-specific antigenicity, too. However, both internal antigens are of less importance for the immunity. The essential antigens are the hemagglutinin and the neuraminidase. Both are surface antigens and subject to a permanent change of their antigenicity, which is called drift or shift. The appearence of permanent new Influenza epidemics and pandemics are particularly facilitated by an antigen variability, because the new drift or shift variants infect a population which is only partly immune or in an extreme case completely susceptible to the disease. The determination of the Influenza type (A, B, and C) gives both the clinician and epidemiologist important indications for further actions. Thus Influenza B often leads to a serious clinical course and an epidemic spread of the virus. Similarly, during an Influenza A epidemic, the epidemiological importance and derived measures for the protection of the individual and population primarily stand in the foreground together with the severity of the clinical symptoms.Principle of the Test:The Influenza A IgM antibody test kit is based on the principle of the enzyme immunoassay (EIA). Influenza A antigen is bound on the surface of the microtiter strips. Diluted patient serum or ready-to-use standards are pipetted into the wells of the microtiter plate. A binding between the IgM antibodies of the serum and the immobilized Influenza A antigen takes place. After a one hour incubation at RT, the plate is rinsed with diluted wash solution, in order to remove unbound material. Then ready-to-use anti-human-IgA peroxidase conjugate is added and incubated for 30 minutes. After a further washing step, the substrate (TMB) solution is pipetted and incubated for 20 minutes, inducing the development of a blue dye in the wells. The color development is terminated by the addition of a stop solution, which changes the color from blue to yellow. The resulting dye is measured spectrophotometrically at the wavelength of 450nm. The concentration of the IgM antibodies is directly proportional to the intensity of the color.Kit Components:Microtiter plate, 1x96 wellsCalibrator A (Negative Control), 1x2mlCalibrator B (Cut-Off Standard) 1x2mlCalibrator C (Weak Positive Control), 1x2mlCalibrator D (Positive Control), 1x2mlEnzyme Conjugate, 1x15mlSubstrate, 1x15mlStop Solution, 15mlSample Diluent, 1x60mlWashing Buffer (10×), 1x60mlStorage and Stability:Store all components at 4°C. Stable for 6 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
- 产品特点
- 针对Influenza A, IgM, BioAssay ELISA Kit Not for use in USA, for Export use only该产品的特点优势,欢迎查阅官网提供的产品说明书。
- 保存建议
- 建议收到Influenza A, IgM, BioAssay ELISA Kit Not for use in USA, for Export use only产品后将其置于4°C保存。
- 其他
- Usbiological公司是美国著名的抗体和生化试剂供应商,生产世界上种类最多的抗体,用于Western Blot、免疫沉淀、免疫荧光、免疫组化和流式细胞术等多种检测方法。Usbiological公司现已拥有超过50,19234种抗体、抗原和生化产品,为科研用户提供了诸多超值选择。
-

- 注意
-
该页面的中文产品信息的翻译,仅供参考。准确的产品信息请以厂家的英文说明书为准。下单前,请浏览说明书确认。
-